Literature DB >> 26655850

Valproic acid: reducing the risks of prenatal exposure.

Kimford J Meador1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26655850      PMCID: PMC6350527          DOI: 10.1016/S1474-4422(15)00357-9

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  9 in total

Review 1.  Valproic acid after five decades of use in epilepsy: time to reconsider the indications of a time-honoured drug.

Authors:  Torbjörn Tomson; Dina Battino; Emilio Perucca
Journal:  Lancet Neurol       Date:  2015-12-05       Impact factor: 44.182

Review 2.  Developmental effects of antiepileptic drugs and the need for improved regulations.

Authors:  Kimford J Meador; David W Loring
Journal:  Neurology       Date:  2015-10-30       Impact factor: 9.910

3.  KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy.

Authors:  Eugen Trinka; Anthony G Marson; Wim Van Paesschen; Reetta Kälviäinen; Jacqueline Marovac; Benjamin Duncan; Sonja Buyle; Yngve Hallström; Petr Hon; Gian Carlo Muscas; Mark Newton; Heinz-Joachim Meencke; Philip E Smith; Bernd Pohlmann-Eden
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-08-29       Impact factor: 10.154

4.  Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy.

Authors:  Tracy A Glauser; Avital Cnaan; Shlomo Shinnar; Deborah G Hirtz; Dennis Dlugos; David Masur; Peggy O Clark; Edmund V Capparelli; Peter C Adamson
Journal:  N Engl J Med       Date:  2010-03-04       Impact factor: 91.245

5.  IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study.

Authors:  Gus A Baker; Rebecca L Bromley; Maria Briggs; Christopher P Cheyne; Morris J Cohen; Marta García-Fiñana; Alison Gummery; Rachel Kneen; David W Loring; George Mawer; Kimford J Meador; Rebekah Shallcross; Jill Clayton-Smith
Journal:  Neurology       Date:  2014-12-24       Impact factor: 9.910

6.  Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism.

Authors:  Jakob Christensen; Therese Koops Grønborg; Merete Juul Sørensen; Diana Schendel; Erik Thorlund Parner; Lars Henning Pedersen; Mogens Vestergaard
Journal:  JAMA       Date:  2013-04-24       Impact factor: 56.272

7.  Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study.

Authors:  Kimford J Meador; Gus A Baker; Nancy Browning; Morris J Cohen; Rebecca L Bromley; Jill Clayton-Smith; Laura A Kalayjian; Andres Kanner; Joyce D Liporace; Page B Pennell; Michael Privitera; David W Loring
Journal:  Lancet Neurol       Date:  2013-01-23       Impact factor: 44.182

8.  Intended and unintended pregnancies worldwide in 2012 and recent trends.

Authors:  Gilda Sedgh; Susheela Singh; Rubina Hussain
Journal:  Stud Fam Plann       Date:  2014-09

9.  The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial.

Authors:  Anthony G Marson; Asya M Al-Kharusi; Muna Alwaidh; Richard Appleton; Gus A Baker; David W Chadwick; Celia Cramp; Oliver C Cockerell; Paul N Cooper; Julie Doughty; Barbara Eaton; Carrol Gamble; Peter J Goulding; Stephen J L Howell; Adrian Hughes; Margaret Jackson; Ann Jacoby; Mark Kellett; Geoffrey R Lawson; John Paul Leach; Paola Nicolaides; Richard Roberts; Phil Shackley; Jing Shen; David F Smith; Philip E M Smith; Catrin Tudur Smith; Alessandra Vanoli; Paula R Williamson
Journal:  Lancet       Date:  2007-03-24       Impact factor: 79.321

  9 in total
  2 in total

1.  Failures in reproductive health policy: overcoming the consequences and causes of inaction.

Authors:  Jonathan Sher; John W Frank; Lawrence Doi; Linda de Caestecker
Journal:  J Public Health (Oxf)       Date:  2019-06-01       Impact factor: 2.341

2.  Analytical Method Development for Sodium Valproate through Chemical Derivatization.

Authors:  Murad Abualhasan; Nihaya Wasif Odeh; Ghadeer Naser Younis; Oyoun Fadel Zeidan
Journal:  Int J Anal Chem       Date:  2020-01-31       Impact factor: 1.885

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.